/rss/research-newsFind news related to research at Mayo Clinic.en-USKonstantinos Lazaridis, M.D., in Mayo Clinic’s Kellen Building, where he leads research into the exposome. Standing in a laboratory amid technologies capable of probing human biology at extraordinary scale and depth, Konstantinos Lazaridis, M.D., is leading Mayo Clinic's effort to understand the exposome — the totality of environmental exposures that can influence human health. The exposome is, in many ways, a record of a life lived — the air someone breathes, the food and water…https://newsnetwork.mayoclinic.org/?p=417999Tuesday, October 27, 2026ROCHESTER, Minn., and PHOENIX — A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining tissue through biopsy is difficult or potentially unsafe. The study included 76 patients facing one of three challenging clinical scenarios: An abnormality in the brain or spinal cord without a diagnosis; Imaging changes that could reflect…https://newsnetwork.mayoclinic.org/?p=419046Monday, October 26, 2026ROCHESTER, Minn. — An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. The findings, published in Nature Medicine, will help researchers design a larger phase 3 clinical trial. Nearly every patient evaluated after receiving the vaccine developed an immune response against mutated KRAS, a gene that plays a major role in pancreatic…https://newsnetwork.mayoclinic.org/?p=419007Friday, October 23, 2026ROCHESTER, Minn. — Mayo Clinic researchers have found that an artificial intelligence (AI) tool may provide dermatologists with additional information to help assess whether skin lesions are cancerous and inform their clinical decisions about whether to biopsy or monitor them, according to a study published in Mayo Clinic Proceedings. The tool, called Dermoscopy Explainable Intelligence (DEXI), is part of an advanced imaging system that dermatologists use to capture and track skin lesions over time. DEXI…https://newsnetwork.mayoclinic.org/?p=418962Thursday, October 22, 2026ROCHESTER, Minn. — Mayo Clinic researchers are studying whether low-dose radiation therapy can slow the progression of Parkinson's disease by targeting inflammation in areas of the brain affected by the disease. The clinical trial is the first to investigate low-dose radiation as an anti-inflammatory approach in patients with early-stage Parkinson's disease. Radiation therapy is most often used to treat cancer, where higher doses are used to damage tumor cells and stop them from growing. In…https://newsnetwork.mayoclinic.org/?p=418886Wednesday, October 21, 2026This special Mayo Clinic series highlights research advancing Precure Research by detecting risk earlier, intervening sooner and preventing disease.https://newsnetwork.mayoclinic.org/?p=417980Tuesday, October 20, 2026Getty Images JACKSONVILLE, Fla. — People who develop pancreatic cancer experience measurable changes in body composition years before diagnosis that differ from those seen in similar individuals without cancer, according to a Mayo Clinic study led by former Mayo Clinic research fellow, Aleksander Bogdanski and published in Pancreatology. Pancreatic cancer remains one of the deadliest cancers, largely because most patients are diagnosed after the disease has already spread. Current surveillance programs focus primarily on people…https://newsnetwork.mayoclinic.org/?p=418858Tuesday, October 20, 2026Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.https://newsnetwork.mayoclinic.org/?p=418442Monday, October 19, 2026ROCHESTER, Minn. — Researchers in a Mayo Clinic-led study have shown how to detect a broad range of DNA mutations in noncancerous human tissues and across the genome. The analysis, drawing on more than 90 trillion DNA letters of sequencing data, could help scientists study when these changes arise — from early development through aging — and how they contribute to cancer and other diseases.  Published in Cell, the study is the flagship paper in…https://newsnetwork.mayoclinic.org/?p=418735Thursday, October 15, 2026The liver is the body's largest internal organ, helping to digest food, remove waste and make proteins. It's essential for life.    When part of the liver is removed to treat cancer or other conditions, the remaining tissue must regenerate to restore liver function.   In this Mayo Clinic Minute, Dr. Patrick Starlinger, a hepatobiliary and pancreas surgeon at Mayo Clinic Comprehensive Cancer Center, discusses research to help the liver regenerate after surgery.  Watch: The Mayo Clinic…https://newsnetwork.mayoclinic.org/?p=418597Wednesday, October 14, 2026Margot Cousin, Ph.D., works at a cell-culture microscope as Kaitlyn Dirks, a first-year graduate student in the Virology and Gene Therapy track, looks on in Dr. Cousin’s laboratory at Mayo Clinic. Mayo Clinic scientists are pushing medicine beyond diagnosis, developing treatments for ultrarare genetic diseases while building a model that could accelerate the path to treatment for many more.  Behind the glass walls of her Mayo Clinic neuroscience laboratory, Margot Cousin, Ph.D., watches tiny clusters…https://newsnetwork.mayoclinic.org/?p=418020Tuesday, October 13, 2026Landmark ATOMIC trial brings immunotherapy to patients being treated with the goal of cure ROCHESTER, Minn. — The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR. The approval is based on results from the ATOMIC clinical trial led by Mayo Clinic. The study found…https://newsnetwork.mayoclinic.org/?p=418504Friday, October 9, 2026Prostate cancer is one of the most common cancers in men, and finding it early can expand treatment options, including highly precise radiation that targets the tumor while protecting nearby tissue. Watch: The Mayo Clinic Minute https://www.youtube.com/watch?v=dYWRfx4zNg4 Journalists: Broadcast-quality video (1:00) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script. Screening for prostate cancer can start with a blood test. A prostate-specific antigen, or PSA, test measures…https://newsnetwork.mayoclinic.org/?p=417658Wednesday, October 7, 2026What doctors can't see can make glioblastoma especially difficult to treat.  This aggressive brain cancer can extend beyond what's visible on a standard MRI, making it difficult to precisely target treatment. Just 5% to 7% of patients survive five years after diagnosis.  Mayo Clinic researchers are studying advanced imaging techniques designed to bring more of the tumor into view and potentially give care teams a better-defined target.  "We're trying to develop and improve treatments that…https://newsnetwork.mayoclinic.org/?p=418253Tuesday, October 6, 2026"Alan Alwakeel (left), SPARK scholar, works on research in the lab with a Mayo Clinic research scientist. Long before he set foot in a research lab, Alan Alwakeel was already asking big questions about medicine, technology and how to bring the two together. By the time he entered Mayo Clinic's SPARK (Science Program for the Advancement of Research Knowledge) program as a high school junior in the summer of 2024, he also was no stranger…https://newsnetwork.mayoclinic.org/?p=418353Thursday, October 1, 2026Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS. https://newsnetwork.mayoclinic.org/?p=417869Thursday, October 1, 2026Ruben Mars, Ph.D., works within an anaerobic chamber in the Microbiomics Program laboratory at Mayo Clinic. Mayo Clinic findings also link specific gut bacteria to cancer survival and identify a pretreatment signal associated with chemotherapy toxicity ROCHESTER, Minn. — Mayo Clinic researchers have discovered distinct gut microbiome patterns in adults age 50 or younger with colorectal and breast cancers compared with those diagnosed later in life — one of several findings from an analysis of…https://newsnetwork.mayoclinic.org/?p=417910Tuesday, September 29, 2026ROCHESTER, Minn. — Mayo Clinic researchers led a multicenter study that found dividing radiation into several treatments, known as fractionated stereotactic radiosurgery, reduced the risk of cancer returning after surgery for brain metastases and was associated with improved survival compared with delivering radiation in a single treatment. The findings are being presented today at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting in Boston. Brain metastases, also called metastatic brain tumors, are cancerous…https://newsnetwork.mayoclinic.org/?p=418244Monday, September 28, 2026Getty Images ROCHESTER, Minn. — Mayo Clinic researchers will present findings on emerging technologies, precision treatments and new radiation therapy techniques at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 26–30 in Boston. Mayo Clinic experts will participate in nearly 65 poster, education, quick-pitch, scientific, oral, plenary and presidential sessions and present 45 abstracts. Their presentations will cover topics ranging from artificial intelligence (AI) and advanced technologies in radiation therapy to clinical…https://newsnetwork.mayoclinic.org/?p=418166Friday, September 25, 2026Getty Images ROCHESTER, Minn. — A large prospective study published today in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests. Mayo Clinic was among the institutions participating in the prospective, interventional study, which enrolled 35,878 adults age 50 and older. Karthik Giridhar, M.D., a Mayo Clinic…https://newsnetwork.mayoclinic.org/?p=418111Tuesday, September 22, 2026